Alzamend Neuro Inc.
10/09/2025 | Press release | Distributed by Public on 10/09/2025 14:30
Private Placement (Form 8-K)
| Item 3.02 | Unregistered Sales of Equity Securities. |
Between October 1, 2025 and October 8, 2025, Alzamend Neuro, Inc. (the "Company") issued an aggregate of 361,743 shares of common stock, par value $0.0001 per share ("Common Stock") upon conversion of an aggregate of approximately 839.2 shares of Series B Convertible Preferred Stock. The shares of Common Stock were issued in reliance upon exemption from the registration requirements under Section 4(a)(2) under the Securities Act.
As of October 8, 2025, the Company had 3,801,604 shares of Common Stock outstanding.
Alzamend Neuro Inc. published this content on October 09, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on October 09, 2025 at 20:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]